PathogenDx CEO Milan Patel Calls on President Joe Biden to Implement Newest State of the Art Diagnostic Technologies in Global Battle against COVID-19 Variants

January 13, 2022

While the FDA is considering Emergency Use Authorization submissions for SARS-CoV-2 variant genotyping assays, PathogenDx co-founder and CEO Milan Patel issued the following letter to U.S. President Joe Biden, urging him to implement state of the art diagnostic technologies in the battle against the COVID-19 pandemic.

Read letter »